Calumet (CLMT) Stock Price, News & Analysis

Company Overview

Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.

Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions. The company invests in research and development to advance next-generation formulations such as renewable diesel feedstocks and proprietary lubricant chemistries. Its technical service teams work closely with customers to develop application-specific blends and improve operational efficiencies.

With operations concentrated in the United States and Canada, Calumet maintains strategically located refineries, blending centers and terminals to support reliable distribution and just-in-time delivery. The company’s North American footprint, combined with export channels and distributor partnerships, enables it to serve a global customer base. Focusing on operational excellence, asset reliability and sustainable product development, Calumet continues to pursue growth in specialty hydrocarbon and renewable energy markets.

Key Stats

• Today's Range: $17.16 to $17.96
• 50-Day Range: $13.23 to $17.84
• 52-Week Range: $7.68 to $25.29
• Volume: 742,471 shs
• Average Volume: 849,507 shs
• Market Capitalization: $1.50 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $18.71
• Consensus Rating: Moderate Buy

Calumet Stock Analysis - MarketRank™

Calumet scored higher than 17% of companies evaluated by MarketBeat, and ranked 250th out of 266 stocks in the energy sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.2 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Calumet has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 4 buy ratings, 2 hold ratings, and no sell ratings.

Upside/Downside

The consensus price target for Calumet is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

Calumet has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Calumet are expected to grow in the coming year, from ($3.02) to $0.15 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Calumet is -3.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Calumet is -3.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

15.02% of the float of Calumet has been sold short.

Short Interest Ratio / Days to Cover

Calumet has a short interest ratio ("days to cover") of 9.8.

Change versus previous month

Short interest in Calumet has recently increased by 7.44%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Calumet does not currently pay a dividend.

Dividend Growth

Calumet does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

15.02% of the float of Calumet has been sold short.

Short Interest Ratio / Days to Cover

Calumet has a short interest ratio ("days to cover") of 9.8.

Change versus previous month

Short interest in Calumet has recently increased by 7.44%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: 0.92

News Sentiment

Calumet has a news sentiment score of 0.92. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Energy companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Calumet this week, compared to 4 articles on an average week.

Search Interest

Only 1 people have searched for CLMT on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

MarketBeat Follows

1 people have added Calumet to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Calumet insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,796,303.00 in company stock.

Percentage Held by Insiders

Only 4.07% of the stock of Calumet is held by insiders.

Percentage Held by Institutions

Only 34.41% of the stock of Calumet is held by institutions.

CLMT Stock Analysis - Frequently Asked Questions

How have CLMT shares performed this year?

Calumet's stock was trading at $22.02 at the beginning of the year. Since then, CLMT shares have decreased by 21.6% and is now trading at $17.27.

How were Calumet's earnings last quarter?

Calumet, Inc. (NASDAQ:CLMT) posted its quarterly earnings results on Friday, August, 8th. The oil and gas company reported ($1.70) EPS for the quarter, missing the consensus estimate of ($0.44) by $1.26. Calumet's quarterly revenue was down 9.4% compared to the same quarter last year.
Read the conference call transcript.

Does Calumet have any subsidiaries?

The following companies are subsidiaries of Calumet: Biosynthetic Technologies, Specialty Oil Field Solutions, Anchor Drilling Fluids USA, United Petroleum Company, Bel-Ray, Montana Renewables, Royal Purple, and others.

Who are Calumet's major shareholders?

Calumet's top institutional shareholders include Wasserstein Debt Opportunities Management L.P. (6.75%), Adams Asset Advisors LLC (6.27%), Two Seas Capital LP (5.22%) and Knott David M Jr (3.80%). Insiders that own company stock include Jennifer Straumins, James S Carter, Stephen P Mawer, Scott Obermeier, Daniel J Sajkowski, Gregory J Morical, Ryan Willman and David Lunin.
View institutional ownership trends.

How do I buy shares of Calumet?

Shares of CLMT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Calumet own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Calumet investors own include Chembio Diagnostics (CEMI), Prospect Capital (PSEC), Two Harbors Investments (TWO), BlackRock Capital Investment (BKCC), NovoCure (NVCR), Viper Energy (VNOM) and Summit Midstream Partners (SMLP).

Company Calendar

• Last Earnings: 8/08/2025
• Today: 9/08/2025
• Next Earnings (Estimated): 11/14/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Energy
• Industry: OIL - US INTEGRTD
• Sub-Industry: Petroleum And Natural Gas
• Current Symbol: NASDAQ:CLMT
• CIK: 1340122
• Web: www.calumetspecialty.com
• Phone: (317) 328-5660
• Fax: 317-328-2359
• Employees: 1,620
• Year Founded: 1916

Price Target and Rating

• Average Price Target for Calumet: $18.71
• High Price Target: $33.00
• Low Price Target: $13.25
• Potential Upside/Downside: +8.5%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.67
• Research Coverage: 6 Analysts

Profitability

• EPS (Trailing Twelve Months): ($5.22)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$222 million
• Net Margins: -11.09%
• Pretax Margin: -11.07%
• Return on Equity: N/A
• Return on Assets: -12.65%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.76
• Quick Ratio: 0.45

Sales & Book Value

• Annual Sales: $4.19 billion
• Price / Sales: 0.36
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($8.28) per share
• Price / Book: -2.08

Miscellaneous

• Outstanding Shares: 86,750,000
• Free Float: 83,221,000
• Market Cap: $1.50 billion
• Optionable: Optionable
• Beta: 0.97